Key result
In patients undergoing transcatheter mitral valve repair, acute kidney injury occurred in 13.6% and was associated with increased in-hospital mortality (aOR 4.94; 95% CI 2.92-8.34).
Why the study?
Although transcatheter mitral valve repair is contrast-free, prior single-center studies showed a high incidence of acute kidney injury, prompting evaluation of its risk factors and clinical outcomes.
Is acute kidney injury associated with worse clinical outcomes in patients undergoing transcatheter mitral valve repair?
Cohort (n=14,623)
Yes
Is acute kidney injury associated with worse clinical outcomes in patients undergoing transcatheter mitral valve repair?
Odds Ratio: 4.94 (95% CI 2.92–8.34)
Acute kidney injury is a common complication following transcatheter mitral valve repair and is strongly associated with increased in-hospital mortality and 30-day readmissions.
INTRODUCTION: Although transcatheter mitral valve repair (TMVr) is a contrast-free procedure, prior single-center studies have demonstrated a high incidence of acute kidney injury (AKI) following TMVr. The main objective of this study was to examine risk factors for AKI, and its association with outcomes in patients undergoing TMVr. METHODS: We queried the National Readmission Database to identify TMVr procedures performed between January 2014 and December 2017. Complex samples multivariable logistic and linear regression models were used to identify risk factors associated with AKI, as well as to determine the association between AKI and clinical outcomes (in-hospital mortality, index length of stay (LOS), 30-day all-cause readmissions, and 30-day heart failure [HF] readmissions). RESULTS: Of 14,623 patients who underwent TMVr during the study period, 2,001 (13.6%) had a diagnosis of AKI. HF, chronic kidney disease, chronic liver disease, fluid/electrolyte disorder, weight loss, nonelective admission, cardiogenic shock, and bleeding/transfusion were independently associated with an increased risk of AKI. In patients undergoing TMVr, AKI was associated with an increased risk of in-hospital mortality (adjusted odds ratio [aOR], 4.94; 95% confidence interval [CI], 2.92-8.34), 30-day all-cause readmissions (aOR, 1.91; 95% CI, 1.49-2.46), 30-day HF readmissions (aOR, 2.30; 95% CI, 1.38-3.84), and longer index LOS (adjusted parameter estimate, 5.78; 95% CI, 5.26-6.41). CONCLUSION: AKI in the setting of TMVr is common and is associated with worse clinical outcomes. Further studies are needed to determine if optimizing renal function prior to TMVr may improve outcomes, as well as to understand the impact of TMVr itself on renal function.
No takes yet. Share an insight, caveat, or question.
Nazir et al. (2021) conducted a cohort in Transcatheter mitral valve repair (n=14,623). Acute kidney injury vs. No acute kidney injury was evaluated on In-hospital mortality (aOR 4.94, 95% CI 2.92-8.34). In patients undergoing transcatheter mitral valve repair, acute kidney injury occurred in 13.6% and was associated with increased in-hospital mortality (aOR 4.94; 95% CI 2.92-8.34).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: